Skip to Main Content
Close
Who We Serve
Overview
Researchers
Authors
Reviewers
Healthcare Professionals
Patients & Their Supporters
Librarians
Health Sciences Industry
Medical Societies
Agents & Distributors
What We Offer
Overview
Journals
Collections
Subject Areas
Books & Book Series
E-Learning Courses
Healthcare Podcasts
Open Access Portfolio
Communications & Outreach
Who We Are
Overview
What We Solve
Accessing Knowledge
Presenting Knowledge
Applying Knowledge
About Us
Publish with Us
Overview
Publish Your Paper
Calls for Papers
Publication Services
Partner Publications
Submit & Publish Open Access
Resources for You
Overview
Exhibitions
Webinars
Case Studies
Fast Facts
News & Media Releases
Experience Karger Blog
The Waiting Room Blog
Research Viewpoints Blog
Search Dropdown Menu
Advanced Search
User Tools Dropdown
Register
Login
Toggle Menu
Menu
Content
Articles
Issues
Online First
Early View
About
Details
Contact
Editorial Board
Guidelines
Affiliations
Subscription Rates
Rights & Permissions
Advertising
Submission
Skip Nav Destination
Digestion
Submission
Latest
Most Read
Most Cited
Management of T1 colorectal cancer
Efficacy of donor-recipient-matched faecal microbiota transplantation in patients with IBS-D: A single-centre, randomized, double-blind placebo-controlled study
Randomized controlled trial of remimazolam compared with placebo in Japanese patients undergoing colonoscopy: A phase III, investigator-initiated trial
Antibodies targeting the tumor necrosis factor (TNF) -like ligand 1A (TL1A) in Inflammatory Bowel Disease – a new kid on the (biologics) block?
Close Modal
Close Modal
This Feature Is Available To Subscribers Only
Sign In
or
Create an Account
Close Modal
Close Modal
